BRESCIANI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 7.424
AS - Asia 4.067
EU - Europa 3.805
SA - Sud America 536
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 15.901
Nazione #
US - Stati Uniti d'America 7.270
SG - Singapore 1.185
IT - Italia 1.021
VN - Vietnam 1.001
CN - Cina 942
DE - Germania 676
RU - Federazione Russa 524
HK - Hong Kong 502
BR - Brasile 430
SE - Svezia 313
IE - Irlanda 307
GB - Regno Unito 217
UA - Ucraina 203
CA - Canada 120
FI - Finlandia 115
AT - Austria 100
IN - India 97
ID - Indonesia 82
FR - Francia 76
KR - Corea 63
PL - Polonia 48
BE - Belgio 41
AR - Argentina 38
NL - Olanda 38
DK - Danimarca 37
TR - Turchia 37
BD - Bangladesh 32
JP - Giappone 30
ZA - Sudafrica 27
MX - Messico 25
CH - Svizzera 21
ES - Italia 19
EC - Ecuador 17
IQ - Iraq 14
CO - Colombia 13
PY - Paraguay 12
BG - Bulgaria 11
CZ - Repubblica Ceca 11
IR - Iran 10
KE - Kenya 9
VE - Venezuela 9
TW - Taiwan 8
EG - Egitto 7
PK - Pakistan 7
RO - Romania 7
LT - Lituania 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CL - Cile 5
EU - Europa 5
JM - Giamaica 5
LB - Libano 5
MY - Malesia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
EE - Estonia 4
MA - Marocco 4
NP - Nepal 4
PE - Perù 4
AZ - Azerbaigian 3
BO - Bolivia 3
JO - Giordania 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SC - Seychelles 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 15.901
Città #
Ann Arbor 1.573
Singapore 788
Ashburn 652
Woodbridge 509
Hong Kong 501
Wilmington 501
Frankfurt am Main 464
Chandler 445
Fairfield 436
Ho Chi Minh City 314
Milan 314
Dublin 297
Houston 248
Hanoi 233
Seattle 224
Beijing 207
Jacksonville 189
New York 176
Dearborn 172
Dallas 152
Santa Clara 139
Cambridge 137
Los Angeles 126
Princeton 112
Hefei 109
Vienna 88
Jakarta 77
Nanjing 73
Buffalo 57
Moscow 56
Shanghai 56
Seoul 55
Helsinki 53
Chicago 52
Altamura 45
São Paulo 45
Lawrence 42
London 42
Rome 42
Brussels 40
Munich 40
Guangzhou 38
Council Bluffs 37
Kent 33
Boardman 32
Haiphong 32
Lachine 32
Da Nang 31
Fremont 27
Nuremberg 27
San Diego 27
The Dalles 27
Tokyo 27
Warsaw 27
Biên Hòa 25
Pune 24
Elora 23
Ha Long 21
Nanchang 21
Andover 20
Dong Ket 20
Toronto 20
Poplar 19
Can Tho 18
Changsha 18
Shenyang 18
Turku 18
Detroit 17
Hebei 17
Monza 17
Denver 16
Romola 16
Bari 15
Brooklyn 15
Quận Bình Thạnh 15
Rio de Janeiro 15
San Francisco 15
Stockholm 15
Carate Brianza 14
Orem 14
Jinan 13
Turin 13
Hải Dương 12
Johannesburg 12
Kunming 12
Sacramento 12
Thái Nguyên 12
Atlanta 11
Columbus 11
Falls Church 11
Hangzhou 11
Phoenix 11
Tampa 11
Ankara 10
Boston 10
Bắc Ninh 10
Ningbo 10
Plovdiv 10
Tianjin 10
Vũng Tàu 10
Totale 10.966
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 472
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 448
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 426
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 414
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 409
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 406
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 396
Growth hormone secretagogues and the regulation of calcium signaling in muscle 390
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 347
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 320
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 308
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 299
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 297
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 295
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 273
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 265
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 263
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 263
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 257
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 256
Feeding behavior during long-term hexarelin administration in young and old rats 250
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 248
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 246
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 242
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 241
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 241
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 240
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 239
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 239
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 238
Ghrelin in gastroenteric pathophysiology 237
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 229
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 229
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 226
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 226
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 224
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 223
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 223
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 217
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 214
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 213
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 212
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 209
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 209
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 208
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 208
Androgen therapy in neurodegenerative diseases 207
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 204
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 201
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 193
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 191
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 189
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 185
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 177
The role of androgens in women's health and wellbeing 172
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 168
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 167
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 165
La somatopausa: nuove prospettive terapeutiche 162
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 157
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 136
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 136
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 135
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 127
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 109
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 100
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 95
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 93
Role of nutrition in degenerative disease 80
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model 29
Totale 16.313
Categoria #
all - tutte 50.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.019 0 0 0 0 0 150 128 143 138 164 137 159
2021/20221.033 116 109 121 83 56 75 46 46 30 86 96 169
2022/20231.866 186 484 216 182 142 268 31 118 115 19 56 49
2023/20241.156 38 58 67 77 134 281 218 52 74 23 21 113
2024/20252.808 153 234 213 189 234 166 220 133 168 376 237 485
2025/20264.194 1.294 689 578 780 809 44 0 0 0 0 0 0
Totale 16.313